Study of AZD0754 in Participants With Metastatic Prostate Cancer

Clinical trial NCT06267729 · RECRUITING

Trial details

NCT number: NCT06267729
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Prostate Cancer

Start date: 2024-03-12
Primary completion: 2026-11-24
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.